Intra Cellular Therapies reported $-77324000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
ALKERMES ALKS:US -19659000 24.08M
Aptinyx Inc APTX:US $ -21206000 1.34M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Biogen BIIB:US $ 794M 308.3M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cytokinetics CYTK:US $ -69.2M 14.4M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Gilead Sciences GILD:US $ 3842M 1596M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Intra Cellular Therapies ITCI:US $ -77.32M 8.18M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Johnson & Johnson JNJ:US $ 3849M 2813M
Marinus Pharmaceuticals MRNS:US $ -19.17M 4.32M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NVS:US $ 3233M 246M
Prothena PRTA:US 109.23M 81.28M
Redhill Biopharma RDHL:US $ -24.89M 6.73M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vanda Pharmaceuticals VNDA:US $ 10.82M 1.55M
Zogenix ZGNX:US $ -53.87M 1.56M